Induction of T cell proliferation and cytotoxicity by lymphokines by Männel, D.N. et al.
LYMPHOKINE RESEARCH 
Volume 4, Number 2, 1985 
Mary Ann Liebert, Inc., Publishers 
SUMMARY ARTICLE 
Induction of T Cell Proliferation and 
Cytotoxicity by Lymphokines 
DANIELA N. MANNEL, WERNER FALK, and W. DROGE 
INTRODUCTION 
Induction of cytotoxic T lymphocyte (CTL) responses i n v i t r o requires a series 
of d i s c r e t e a c t i v a t i o n s i g n a l s . CTL-precursors (CTL-p) express receptors 
for the T c e l l growth factor i n t e r l e u k i n 2 (IL-2) a f t e r an i n i t i a l antigen 
or mitogen stimulus. The presence of IL-2 i s necessary for sustained T c e l l 
growth, i . e . , IL-2 receptor-bearing T c e l l s expand c l o n a l l y by consuming 
IL-2 (1~3). Requirement f or other lymphokines to convert CTL-p into func-
t i o n a l CTL-effector c e l l s has been described previously (4-8). 
In mixed lymphocyte c u l t u r e s , a l l necessary helper signals are provided 
by c e l l s w i t h i n the c u l t u r e s . Culture conditions with lim i t e d helper poten-
t i a l were established i n order to study the required helper mediators. When 
l i m i t e d numbers ( 1 0
5
) of unfractionated thymocytes were cultured i n the 
presence of metabolically i n a c t i v e stimulator c e l l s , even very high concen-
t r a t i o n s of p u r i f i e d mouse or recombinant human IL-2 were unable to induce 
either p r o l i f e r a t i v e or cytotoxic responses ( 8 ) . 
A T CELL-DERIVED CYTOTOXICITY-INDUCING FACTOR 
Coculture of 10
 5
 thymocytes with metabolically active allogeneic stimulator 
c e l l s i n the presence of s u f f i c i e n t amounts of IL-2 re s u l t s i n antigen-
s p e c i f i c cytotoxic responses. The l e v e l of cytotoxic a c t i v i t y after 5 days 
of culture was dependent on the number of metabolically active stimulator 
c e l l s but was not dependent on the amount of antigen that was presented. 
Therefore, a l l required helper signals were generated within these c u l t u r e s . 
In the absence of metabolically active stimulator c e l l s , however, no cyto-
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t o x i c i t y was found even i n IL-2 excess. I t was possible to replace the meta-
bolic- a c t i v i t y of the stimulator c e l l s by adding a T c e l l c y t o t o x i c i t y -
inducing factor (TCF1) preparation to these d e f i c i e n t c u l t u r e s ( 8 ) . 
This soluble helper mediator was obtained from supernatants of several T 
c e l l sources a f t e r stimulation but not from c e l l s of the macrophage line a g e . 
Good a c t i v i t y was found i n supernatants of several subclones of the EL-4 c e l l 
l i n e a f t e r PMA-stimulation or i n Con A-pulsed spleen c e l l supernatants ( 9 ) . 
In culture supernatants from c e l l s of other o r i g i n even a f t e r a v a r i e t y of 
stimulation procedures, no such a c t i v i t y was detected. Contaminating mitogen 
was not responsible for the c y t o t o x i c i t y - i n d u c i n g e f f e c t of TCF1. Con A 
at the highest possible contaminating dose i n the TCF1 preparations was unable 
to generate cytotoxic responses even i n the presence of IL-2. The a c t i v i t y 
was H-2 nonspecific, s e n s i t i v e to pronase, t r y p s i n , and chymotrypsin, re-
si s t a n t to neuraminidase, r e l a t i v e l y heat l a b i l e (T^ at 56°C=4 minutes), 
and stable within a pH range from 3 to 10. Preliminary r e s u l t s from gel f i l -
t r a t i o n revealed a molecular weight of about 40 KD for the EL-4-derived TCF1. 
TCF1-INDUCED CYTOTOXIC RESPONSES 
Cytotoxic responses of thymocytes measured i n the presence of excess 
amounts of IL-2 i n l e c t i n - f r e e cultures were TCF1 dose-dependent (Table 1 ) . 
Table 1. TCFl-Dependent Cytotoxic Responses 
Sample* % S p e c i f i c [
5 1
C r ] Release
1
" 
Medium 2.5 ± 0.7 
IL-2 3.6 ± 2.0 
TCF1 20 nl 2.2 ± 1.6 
TCF1 40
 u
l 5.0 ± 1.8 
IL-2 + 20 u l TCF1 21.3 ± 5.9 
IL-2 + 40 y l TCF1 35.9 ± 14.4 
-"The cultures contained either p u r i f i e d IL-2 (20 U/ml) or no IL-2 and 
graded amounts of .TCF1 from IL-2-absorbed Con A-pulsed spleen • c e l l 
supernatants. 
"^Cytotoxic responses of 10
 5
 C3H thymic responder c e l l s i n the presence 
of 3 x 10
 5
 TNP-modified glutaraldehyde-fixed C3H sple n i c stimulator c e l l s 
were determined i n a 4 hour [
5 1
 Cr ]-release test on day 5 on 5 x 10
3
 TNP-
modified L929 tumor t a r g e t s . 
The presence of TCF1 for 48 hours was s u f f i c i e n t to induce optimal cyt o t o x i c 
responses (10). The ef f e c t of TCF1 was not due to other known lymphokines, 
such as in t e r f e r o n Y (IFN-Y), colony-stimulating factor (CSF), or i n t e r l e u k i n 
1 (IL-1) (11). Cytotoxic responses on day 5 were s e n s i t i v e to Lyt 2-antibody 
and complement treatment, and >80% of the viable c e l l s were p o s i t i v e for 
Thy 1 and Lyt 2 i n the fluorescence-activated c e l l s o r t i n g analysis 
thus carrying surface markers of CTL. Cold target i n h i b i t i o n studies suggested 
that the cytotoxic resonses were p o l y c l o n a l . Experiments i n autologous mouse 
serum showed that the polyclonal e f f e c t was' not due to the presence of f e t a l 
c a l f serum i n the c u l t u r e s . In t h i s nonspecific action and also i n the i r 
morphologic appearance, the e f f e c t o r c e l l s resemble lymphokine-activated k i l l e r 
c e l l s or large granular lymphocytes (12, 13). 
INDUCTION OF IL-2 RESPONSIVENESS BY TCF1 OR IL-1 
To determine the mechanism of TCF1 a c t i o n , p r o l i f e r a t i v e responses of thymo-
cytes were examined i n the presence of IL-2. When 10
5
 thymocytes of lipopoly-
saccharide-low responder C3H/HeJ mice were incubated with large amounts of 
IL-2 (20 U/ml), only marginal p r o l i f e r a t i o n was measured i n the absence of 
stimulator c e l l s or mitogen. Addition of graded amounts of TCF1 preparations 
led to a dose-dependent p r o l i f e r a t i v e response ( F i g . 1A). Pulse k i n e t i c s 
cont. 
48 h 
1,5 6 25 
ul TCF1 per culture 
20 40 
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FIG. 1. P r o l i f e r a t i v e responses of 2 x 10 C3H/HeJ thymocytes were determined 
a f t e r 48 hours by a 5 hour pulse with t r i t i a t e d thymidine. A. The cultures 
contained e i t h e r p u r i f i e d IL-2 (20 U/ml) or no IL-2 and graded amounts of 
TCF1 from IL-2-absorbed Con A-pulsed spleen c e l l supernatants. B. A l l cultures 
contained p u r i f i e d IL-2 (20 U/ml) for the 72-hour culture period and graded 
amounts of TCF1 from IL-2-absorbed Con A-pulsed supernatants for the indicated 
time period. 
with TCF1 showed that the maximal response was obtained after a 48 hour TCF1 
pulse ( F i g . I B ) . IFN-y preparations were unable to substitute for TCF I . 
However, pure IL-1 preparations that did not cause CTL responses in thymocyte 
cultures were found to also induce IL-2 responsiveness in thymocytes ( F i g . 
2 ) . Using antibodies to IL-1, i t was possible to dis t i n g u i s h between IL-1-
induced and TCFl-induced p r o l i f e r a t i o n . Only the IL-l-induced p r o l i f e r a t i v e 
response of thymocytes was i n h i b i t e d with anti-I.L-1 antibodies but not the 
TCFl-induced IL-2-dependent p r o l i f e r a t i o n . A second parameter to d i f f e r e n -
t i a t e between the two mediators i n t h i s system was the s e n s i t i v i t y to a--methyl-
mannoside ( a l ) , TCFl-induced thymocyte p r o l i f e r a t i o n was abolished in the 
presence of 10 mM a MM, whereas the IL-l-induced p r o l i f e r a t i o n was not affected 
at a l l . I t must again be mentioned that TCF1 i s not a l e c t i n and that the 
trace amounts of Con A i n some TCF1 preparations did not induce any p r o l i f e r -
a t i v e response together with IL-2. 
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FIG, 2. Induction of p r o l i f e r a t i v e responses of A 3 x 10
5
 and B 1 x 10
5 
C3H/HeJ thymocytes with twofold s e r i a l d i l u t i o n of p u r i f i e d I L - 1 . In A, 10 
U of p u r i f i e d murine IL-2 (A) or 5 U of recombinant human IL-2 ( 0 ) and i n 
B, 5 U (A) or 20 U (o) of recombinant human IL-2 were present i n the cultures. 
When the thymocytes were separated according to t h e i r peanut a g g l u t i n i n 
binding capacity by c e l l s o r t i n g , the TCFl-induced c y t o t o x i c i t y as w e l l as 
the TCF1 or IL-l-induced IL-2-dependent p r o l i f e r a t i o n was found i n the low 
binding f r a c t i o n , i . e . , i n the more mature medullary thymocytes. In a d d i t i o n , 
when TCF1 preparations were tested with suboptimal amounts of mitogen i n the 
conventional thymocyte IL-1 assay, they displayed the same a c t i v i t y as the 
con t r o l IL-1 preparations. Again, t h i s TCF1 a c t i v i t y was not i n h i b i t e d with 
a n t i - I L - 1 antibodies. Thus, IL-1, a macrophage product, as w e l l as TCF1, 
a T c e l l product, were both able to confer IL-2 responsiveness to thymocytes 
ei t h e r i n the presence of suboptimal amounts of mitogen or i n the presence 
of IL-2. 
Since the a b i l i t y of T c e l l s to react to IL-2 i s dependent on the expression 
of IL-2 i s dependent on the expression of IL-2 receptors, the induction of 
receptor expression on the c e l l membrane was determined using a monoclonal 
rat antibody (AMT 13) (14). IL-1, TCF1, and IL-2 by themselves were not able 
to induce IL-2 receptors on thymocytes. However, 48 hour incubation of e i t h e r 
IL-1 or TCF1 together with IL-2 led to the binding of AMT 13 antibodies to 
thymocytes (Table 2 ) . IFN-Y with or without IL-2 was unable to induce s i g n i -
f i c a n t IL-2 receptor expression under these c o n d i t i o n s . 
CONCLUSION 
A new function for IL-1 was proposed recently (15). I t i s suggested that 
IL-1 acts together with antigen by inducing IL-2 receptors on susceptible 
T c e l l s rather than by stimulating helper c e l l s for IL-2 production. I t i s 
also suggested that T c e l l s might be able to produce such an I L - l - l i k e a c t i v i t y 
because IL-2 receptor expression and growth of cloned T c e l l s were the outcome 
of a s y n e r g i s t i c action between I L - 2 - r i c h supernatants of T c e l l hybridomas 
and monoclonal antibodies that bind to the antigen receptors (15). 
The data described i n t h i s communication show IL-2 receptor-inducing capa-
b i l i t y of IL-1 i n a completely d i f f e r e n t experimental approach. Moreover, 
TCF1 seems to be the T c e l l product counterpart of t h i s IL-2 responsiveness-
inducing e f f e c t of IL-1. In addition to the induction of IL-2 receptor 
expression and p r o l i f e r a t i o n of thymocytes, however, TCF1 induces cytotoxic 
responses i n the presence of IL-2. This function was not induced by IL-1 
i n the described assay system. I t can be speculated that IL-1 and TCF1 may 
act on d i f f e r e n t subsets of PNA thymocytes or that TCF1 contains an additional 
d i f f e r e n t i a t i o n a c t i v i t y for the stimulated T c e l l s . 
Table 2. Induction of IL-2 Receptor Expression of Thymocytes 







IL-2 + IFN-y 4,470 
IL-2 + IL-1 29,650 
IL-2 + TCF1 37,180 
Con A supernatant 145,680 
-''"Thymocytes (5 x 10
 5
 ) a f t e r exposure to p u r i f i e d IL-2 (80 U/mJ), recombin-
ant IFN-Y (50 U/ml), p u r i f i e d IL-1 (0.50 U/ml) or TCF1 (Con A-pulsed, R e -
absorbed spleen c e l l supernatant, 1:5 diluted) for 48 hours were incubated 
with AMT 13 antibodies. 
+Specific binding of AMT 13 antibodies was determined by binding of 
[ l 2 Z L ] sheep a n t i r a t Ig by c e l l s exposed to AMT 13 or control c e l l s . 
Cytotoxic lymphocyte responses are antigen s p e c i f i c i n bulk c u l t u r e s . 
When TCF1 i s provided exogenously to help d e f i c i e n t c u l t u r e s , t h i s antigen 
s p e c i f i c i t y i s l o s t (16). Assuming that under bulk culture conditions or 
i n vivo TCF1 plays a r o l e for T c e l l a c t i v a t i o n , TCF1 a c t i v i t y has to be linked 
i n some way to the antigen on the d e l i v e r i n g c e l l . Otherwise, polyclonal 
a c t i v a t i o n of CTL precursors by excess TCF1 could not be prevented, and un-
s p e c i f i c cytotoxic responses as measured i n the TCFl-supplemented thymocyte 
cultures would occur. Recently, membrane-bound IL-1 a c t i v i t y was demonstrated 
by Unanue (17). I t i s conceivable that the main form of presentation of 
lymphokine a c t i v i t i e s i s d i r e c t l y from c e l l to c e l l and might require membrane 
contact of the producer c e l l with the target c e l l , thus avoiding nonspecific 
a c t i v a t i o n . 
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